Vivani Medical (VANI) Stock Price, News & Analysis

Company Overview

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Key Stats

• Today's Range: $1.28 to $1.31
• 50-Day Range: $1.11 to $1.35
• 52-Week Range: $0.84 to $7.80
• Volume: 32,224 shs
• Average Volume: 1.06 million shs
• Market Capitalization: $71.29 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VANI Stock Analysis - Frequently Asked Questions

How have VANI shares performed this year?

Vivani Medical's stock was trading at $1.02 on January 1st, 2024. Since then, VANI stock has increased by 26.5% and is now trading at $1.29.
View the best growth stocks for 2024 here.

How were Vivani Medical's earnings last quarter?

Vivani Medical, Inc. (NASDAQ:VANI) posted its earnings results on Tuesday, August, 13th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.12) by $0.02.

How do I buy shares of Vivani Medical?

Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Vivani Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vivani Medical investors own include Second Sight Medical Products (EYES), Enterprise Products Partners (EPD), NextEra Energy Partners (NEP), Palantir Technologies (PLTR), Altimmune (ALT), Caribou Biosciences (CRBU) and Enbridge (ENB).

Company Calendar

• Last Earnings: 8/13/2024
• Today: 11/02/2024
• Next Earnings (Estimated): 11/12/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:VANI
• CUSIP: N/A
• CIK: 1266806
• Web: www.vivani.com
• Phone: (818) 833-5000
• Fax: 818-833-5067
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.47)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-25,650,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -97.30%
• Return on Assets: -48.13%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.55
• Quick Ratio: 4.55

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.41 per share
• Price / Book: 3.15

Miscellaneous

• Outstanding Shares: 55,260,000
• Free Float: 30,778,000
• Market Cap: $71.29 million
• Optionable: Optionable
• Beta: 3.21